BRAFMutation Status in Gastrointestinal Stromal Tumors
2009/12/19 by Isabelle Hostein, Nicolas Faur, Charlotte Primois +11 · 25 citations
Medicine · #Gastrointestinal Tumor Research and Treatment #Sarcoma Diagnosis and Treatment #Neurofibromatosis and Schwannoma Cases
paper · doi:10.1309/ajcppckga2qgbj1r
Abstract
Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors characterized by mutations of KIT or PDGFRA. The objectives of this study were to evaluate BRAF mutations in GISTs and then to correlate BRAF mutational status in the tumor with clinical parameters, with B-raf expression, and with activation of some cellular pathways. BRAF mutation was screened in 321 GISTs with 70 wild-type GISTs. BRAF V600E was detected in 9 (13%) of 70 wild-type GISTs. No mutations were detected in GISTs bearing KIT or PDGFRA mutations. BRAF V600E detection in the tumor does not induce a higher expression of the B-raf protein or the preferential activation of the p42/44 mitogen-activated protein kinase (MAPK) signaling pathway compared with GISTs without the BRAF mutation. In comparison with the GIST group with KIT or PDGFRA mutation or the wild-type GIST group without BRAF mutation, the wild-type GIST group with a BRAF mutation is not different in terms of B-raf expression or the p44/42 MAPK- or AKT-activated signaling pathway.
Cited by
- Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age. [europepmc]
- Recent advances and novel agents for gastrointestinal stromal tumor (GIST). [europepmc]
- No evidence for interference of h&e staining in DNA testing: usefulness of DNA extraction from H&E-stained archival tissue sections. [europepmc]
- Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors. [europepmc]
- Gastrointestinal stromal tumors. [europepmc]
- Drug repurposing for gastrointestinal stromal tumor. [europepmc]
- Succinate dehydrogenase deficiency in pediatric and adult gastrointestinal stromal tumors. [europepmc]
- Hairy cell leukemia-new genes, new targets. [europepmc]
- Surgical resection should be taken into consideration for the treatment of small gastric gastrointestinal stromal tumors. [europepmc]
- Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST). [europepmc]
- Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic. [europepmc]
- Succinate dehydrogenase (SDH) deficiency, Carney triad and the epigenome. [europepmc]
- Molecular characterization and pathogenesis of gastrointestinal stromal tumor. [europepmc]
- Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT / PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece. [europepmc]
- Clinical Diagnosis of Gastrointestinal Stromal Tumor (GIST): From the Molecular Genetic Point of View. [europepmc]
- Prognostic Indicators for Gastrointestinal Stromal Tumors: A Review. [europepmc]
- A smooth muscle-derived, Braf-driven mouse model of gastrointestinal stromal tumor (GIST): evidence for an alternative GIST cell-of-origin. [europepmc]
- Update on Molecular Genetics of Gastrointestinal Stromal Tumors. [europepmc]
- Carney Triad, Carney-Stratakis Syndrome, 3PAS and Other Tumors Due to SDH Deficiency. [europepmc]
- Early and Next-Generation KIT/PDGFRA Kinase Inhibitors and the Future of Treatment for Advanced Gastrointestinal Stromal Tumor. [europepmc]
- Gastrointestinal stromal tumors with BRAF gene fusions. A report of two cases showing low or absent KIT expression resulting in diagnostic pitfalls. [europepmc]
- New treatment strategies for advanced-stage gastrointestinal stromal tumours. [europepmc]
- NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022. [europepmc]
- GISTs with NTRK Gene Fusions: A Clinicopathological, Immunophenotypic, and Molecular Study. [europepmc]
- Molecular Advances in the Treatment of Advanced Gastrointestinal Stromal Tumor. [europepmc]
Related